New Study Identifies Notable Differences in How 6 European Health Agencies Assess Real-World Data

Report Includes Findings from TLV (Sweden), NICE (UK), IQWiG (Germany), HAS (France), AIFA (Italy), and ZIN (Netherlands)

Princeton, NJ—April 18, 2017—Value in Health, the official journal of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), announced today the publication of new research reviewing and comparing the policies of 6 European health technology assessment (HTA) agencies on incorporating real-world data into health technology assessments. Read more ›

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , , , ,

For Women at Risk of Hereditary Breast Cancer, Multigene Test Could Help Extend Life Expectancy

Princeton, NJ—April 17, 2017—Value in Health, the official journal of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), announced today the publication of new research indicating that testing for variants in 7 cancer-associated genes (versus the usual process of testing in just 2 genes) followed by risk-reduction management could cost-effectively improve life expectancy for women at risk of hereditary breast cancer. Read more ›

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , , ,

ISPOR Announces 2017 Scientific Achievement and Leadership Awards

Princeton, NJ—April 4, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced the recipients of its 2017 Scientific Achievement and Leadership Awards today. Read more ›

Posted in Announcements, ISPOR News & Press Tagged with: , ,

New Research Findings: Health Costs for Children With Cancer Are Higher Than for Adolescents, Adults

Substantial Survival Gains in Children Mean That Treatment May Still Be Highly Cost Effective

 

Princeton, NJ—March 21, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today the publication of original research estimating the costs of cancer care in children and adolescents. The study found that treating children with cancer is more costly than treating adolescents or adults. The report of the findings, Costs for Childhood and Adolescent Cancer, 90 Days Pre-Diagnosis and 1-Year Post-Diagnosis: A Population-Based Study in Ontario, Canada, was published in the March 2017 issue of Value in Health.   Read more ›

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , , , , ,

Introducing Novel Guidelines for Patient Engagement in Research

Using Real-World Examples to Inform the Integration of Patients as Full Research Partners in Outcomes Research

 

Princeton, NJ—March 20, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today the publication of suggested guidelines on establishing research partnerships with patients. The report of these novel recommendations for outcomes researchers entitled, Emerging Guidelines for Patient Engagement in Research, was published in the March 2017 issue of Value in Health.   Read more ›

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , , ,

ISPOR Publishes New Task Force Report on Constrained Optimization Methods

Research Methodology Can Help Identify Best Approaches to Achieve Optimal Health Outcomes for Patients

Princeton, NJ—March 14, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) published a new task force report, Constrained Optimization Methods in Health Services Research—An Introduction: Report 1 of the ISPOR Optimization Methods Emerging Good Practices Task Force, in the March 2017 issue of Value in Health. This new task force report provides health care researchers and decision makers with an introductory overview of this important methodology. Read more ›

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , ,

ISPOR Announces Plenary Sessions and Speakers For 22nd Annual International Meeting

Conference to Focus on Timely Theme of Evidence and Value in a Time of Social and Policy Change


Princeton, NJ
—March 6, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced plenary sessions and speakers for its 22nd Annual International Meeting that will be held May 20-24, 2017 in Boston, MA, USA. The conference will focus on significant changes in health care and policy with the timely theme, Evidence and Value in a Time of Social and Policy Change. Read more ›

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , ,

ISPOR’s COMMITMENT TO GLOBAL INCLUSIVITY AND SCIENTIFIC EXCELLENCE

ANNOUNCEMENT


Princeton, NJ
—March 2, 2017—“Science has no geographic boundaries,” said Nancy S. Berg, CEO and Executive Director of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). “Scientific research and development is the basis for the rapid globalization of the ISPOR organization and its ongoing and strategic commitment to diverse stakeholder engagement. Scientific excellence and global inclusivity are key components of our organizational values, and of the global enterprise that our Society continues to reflect, encouraging and stimulating a culture of diverse scientific exchange.” Read more ›

Posted in Announcements, ISPOR News & Press

ISPOR INITIATIVE ADVANCES HIGH-QUALITY VALUE ASSESSMENT FRAMEWORKS FOR HEALTH CARE INTERVENTIONS

Value in Health Themed Issue Examines the Development and Dissemination of High-Quality, Unbiased Frameworks

 

Princeton, NJ—February 27, 2017— The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today the publication of a special theme issue of its flagship journal, Value in Health, devoted to methodological, process, and ethical considerations of value assessment frameworks. Published in the February 2017 issue, this special collection of 22 articles addresses approaches and methods to support the definition and use of high-quality frameworks. Read more ›

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , , , , , , , , , ,

“MAPPING STUDIES” IN COST-UTILITY ANALYSES: NEW RECOMMENDATIONS FROM ISPOR TASK FORCE

Guidance for the Consistent Application of Appropriate Analytical Methods
 

Princeton, NJ—February 14, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) published a new Task Force Report, “Mapping to Estimate Health-State Utility from Non–Preference-Based Outcome Measures: An ISPOR Good Practices for Outcomes Research Task Force Report,” by the Society’s Measurement of Health-State Utility Values for Economic Models in Clinical Studies Task Force in the January 2017 issue of Value in Health. Read more ›

Posted in Announcements, ISPOR News & Press, Value in Health Tagged with: , ,